2016 Q3 Form 10-Q Financial Statement

#000156459017022271 Filed on November 07, 2017

View on sec.gov

Income Statement

Concept 2016 Q3
Revenue $5.268M
YoY Change 13407.69%
Cost Of Revenue $845.0K
YoY Change
Gross Profit $4.423M
YoY Change
Gross Profit Margin 83.96%
Selling, General & Admin $50.50M
YoY Change 148.77%
% of Gross Profit 1141.76%
Research & Development $25.81M
YoY Change 37.82%
% of Gross Profit 583.61%
Depreciation & Amortization $610.0K
YoY Change 408.33%
% of Gross Profit 13.79%
Operating Expenses $25.81M
YoY Change -33.88%
Operating Profit -$72.40M
YoY Change 85.65%
Interest Expense $786.0K
YoY Change 754.35%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$71.60M
YoY Change 84.06%
Income Tax
% Of Pretax Income
Net Earnings -$71.61M
YoY Change 84.07%
Net Earnings / Revenue -1359.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$609.4K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $588.9M
YoY Change 144.67%
Cash & Equivalents $153.7M
Short-Term Investments $435.2M
Other Short-Term Assets $5.100M
YoY Change 155.0%
Inventory $4.300M
Prepaid Expenses
Receivables $3.800M
Other Receivables $1.400M
Total Short-Term Assets $603.5M
YoY Change 148.51%
LONG-TERM ASSETS
Property, Plant & Equipment $3.200M
YoY Change 54.74%
Goodwill
YoY Change
Intangibles $7.385M
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.400M
YoY Change 739.51%
Total Long-Term Assets $13.90M
YoY Change 462.07%
TOTAL ASSETS
Total Short-Term Assets $603.5M
Total Long-Term Assets $13.90M
Total Assets $617.4M
YoY Change 151.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.800M
YoY Change 27.04%
Accrued Expenses $34.40M
YoY Change 121.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $39.10M
YoY Change 120.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $200.0K
YoY Change 0.0%
Total Long-Term Liabilities $200.0K
YoY Change -16.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.10M
Total Long-Term Liabilities $200.0K
Total Liabilities $39.30M
YoY Change 118.65%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $578.1M
YoY Change
Total Liabilities & Shareholders Equity $617.4M
YoY Change 151.67%

Cashflow Statement

Concept 2016 Q3
OPERATING ACTIVITIES
Net Income -$71.61M
YoY Change 84.07%
Depreciation, Depletion And Amortization $610.0K
YoY Change 408.33%
Cash From Operating Activities -$49.26M
YoY Change 54.66%
INVESTING ACTIVITIES
Capital Expenditures -$470.0K
YoY Change 147.37%
Acquisitions
YoY Change
Other Investing Activities -$154.4M
YoY Change -1919.08%
Cash From Investing Activities -$154.9M
YoY Change -1964.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $215.9M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 226.1M
YoY Change 19907.08%
NET CHANGE
Cash From Operating Activities -49.26M
Cash From Investing Activities -154.9M
Cash From Financing Activities 226.1M
Net Change In Cash 21.92M
YoY Change -197.81%
FREE CASH FLOW
Cash From Operating Activities -$49.26M
Capital Expenditures -$470.0K
Free Cash Flow -$48.79M
YoY Change 54.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
287000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
51541000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153679000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
798000
CY2017Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
83000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
365324000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
172000
CY2016Q4 acad Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
1999000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1609000
CY2017Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
254091000
CY2017Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. Recent Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">In November 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-18,&#160;<font style="font-style:italic;">Statement of Cash Flows: Restricted Cash</font>, which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. This guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company expects to adopt this standard on January 1, 2018. The adoption of this ASU will modify the Company&#8217;s current classification within the consolidated statement of cash flows but is not expected to materially impact the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016,<font style="color:#000000;">&#160;the FASB issued ASU 2016-13,&#160;</font><font style="font-style:italic;color:#000000;">Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments</font><font style="color:#000000;">, which changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company is currently evaluating the timing and impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements</font>.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <font style="color:#000000;">March 2016, the FASB issued ASU 2016-09,&#160;</font><font style="font-style:italic;color:#000000;">Compensation-Stock Compensation: Improvements to Employee Share-Based Payment Accounting</font><font style="color:#000000;">, which is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, classification on the statement of cash flows, and accounting for forfeitures. This guidance was effective for annual reporting periods beginning after December 15, 2016, including interim periods within those years. The Company adopted this guidance in the first quarter of 2017 using the modified retrospective transition method. Accordingly, the Company increased its deferred tax assets by $36.8 million, with a corresponding increase to its valuation allowance, to record previously unrecognized excess tax benefits. Additionally, the Company elected to make an accounting policy change to recognize forfeitures as they occur. As a result, the Company recorded an increase to additional paid-in capital and a corresponding increase to accumulated deficit of $0.3 million, respectively, to reflect the incremental stock-based compensation expense that would have been recognized in prior years pursuant to the modified guidance. Additionally, the Company increased its deferred tax assets by $0.1 million, with a corresponding increase to its valuation allowance, to record the excess tax benefit from the change</font>.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, <font style="color:#000000;">the FASB issued ASU 2016-02,&#160;</font><font style="font-style:italic;color:#000000;">Leases</font><font style="color:#000000;">, which requires a lessee to recognize a lease liability and a right-of-use asset for all leases with lease terms of more than 12 months. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those years, and early adoption is permitted. Companies are required to adopt this guidance using a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. While the Company is still evaluating the timing and impact of the adoption of this guidance on its consolidated financial statements, it anticipates that the adoption could result in an increase in the assets and liabilities recorded on its consolidated balance sheet.</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <font style="color:#000000;">May 2014, the FASB issued ASU 2014-09,&#160;</font><font style="font-style:italic;color:#000000;">Revenue from Contracts with Customers</font><font style="color:#000000;">, which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles. This ASU, as amended, is a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts. The original guidance was effective for annual reporting periods beginning after December 15, 2016. However, in July 2015, the FASB agreed to delay the effective date by one year, with early adoption permitted, but not before the original effective date of the standard. Companies may use either a full retrospective or a modified retrospective approach to adopt this guidance. The Company anticipates adopting ASU 2014-09 on January 1, 2018 using the modified-retrospective approach. At present, the Company has one source of revenue: the sale of NUPLAZID to its customers. The Company&#8217;s evaluation of the customer contracts governing these sales is still underway. However, recognition of the Company&#8217;s revenue under the new standard is expected to be materially consistent with the Company&#8217;s current revenue recognition policy, which uses the sell-in method. The new standard is not expected to materially impact the timing or amounts of revenue recognized</font>.</p></div>
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1500000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1000000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2016Q2 acad Regulatory Milestone Payment
RegulatoryMilestonePayment
8000000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8000000
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
400000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1500000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1500000
CY2017Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14463000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39847000
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1820000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2355000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14382000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
9488000
CY2016Q4 acad Accrued Clinical Development Services Current
AccruedClinicalDevelopmentServicesCurrent
8551000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
80000
CY2017Q3 acad Available For Sale Securities Debt Maturities Rolling Year One Through Two
AvailableForSaleSecuritiesDebtMaturitiesRollingYearOneThroughTwo
10900000
CY2016Q4 acad Available For Sale Securities Debt Maturities Rolling Year One Through Two
AvailableForSaleSecuritiesDebtMaturitiesRollingYearOneThroughTwo
0
CY2017Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
365395000
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
523433000
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
281600000
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10344827
acad Number Of Sources Of Revenues
NumberOfSourcesOfRevenues
1

Files In Submission

Name View Source Status
0001564590-17-022271-index-headers.html Edgar Link pending
0001564590-17-022271-index.html Edgar Link pending
0001564590-17-022271.txt Edgar Link pending
0001564590-17-022271-xbrl.zip Edgar Link pending
acad-10q_20170930.htm Edgar Link pending
acad-20170930.xml Edgar Link completed
acad-20170930.xsd Edgar Link pending
acad-20170930_cal.xml Edgar Link unprocessable
acad-20170930_def.xml Edgar Link unprocessable
acad-20170930_lab.xml Edgar Link unprocessable
acad-20170930_pre.xml Edgar Link unprocessable
acad-ex311_11.htm Edgar Link pending
acad-ex312_9.htm Edgar Link pending
acad-ex321_10.htm Edgar Link pending
acad-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending